Anti-Rheumatic Rx

      Biosimilars in Spondyloarthritis
      5 years 3 months ago

      Dr. Rachel Tate from EULAR2020 Virtual Conference 0632

      - ETN Biosimilar in Reactive Arthritis 0650

      - Treasure Study in infliximab biosimilar in SpA

      Easier Early Arthritis
      5 years 3 months ago

      Dr. David Liew from EULAR2020 Virtual Conference

      Early Patient Referrals

      Preclinical RA patients

      Enticing New Options in ANCA-Associated Vasculitis
      5 years 3 months ago

      Dr. David Liew from EULAR2020 ANCA-Associated Vasculitis Avacopan vs Prednisone MAINRITSAN 2 study - Calprotectin

      RT @DrPetryna: How do you approach your PsA patients with suboptimal response to MTX in moderate doses?

      Olga Petryna DrPetryna

      5 years 3 months ago
      How do you approach your PsA patients with suboptimal response to MTX in moderate doses?
      RT @DrPetryna: #EULAR2020 #op0050 RCT ph4 results: in inadequately controlled PsA addition of ADA results in better outc

      Olga Petryna DrPetryna

      5 years 3 months ago
      #EULAR2020 #op0050 RCT ph4 results: in inadequately controlled PsA addition of ADA results in better outcomes in terms MDA, ACR20, PASI75, HAQ-DI&LEI as opposed to MTX dose escalation @RheumNow https://t.co/iMgCkRawCl
      RT @DrPetryna: #EULAR2020 #LB0001 SELECT-PsA-1 Upadacitinib vs PBO vs ADA: UPA 15/30 mg non-inferior &UPA 30 superio

      Olga Petryna DrPetryna

      5 years 3 months ago
      #EULAR2020 #LB0001 SELECT-PsA-1 Upadacitinib vs PBO vs ADA: UPA 15/30 mg non-inferior &UPA 30 superior to ADA for ACR20. At wk12 ACR 20 70.6% UPA15, 78.5% UPA30 vs 36.2%PBO & 65%ADA. Better ACR50/70 &MDA va PBO. No new safety signals. @RheumNow https://t.co/QZkMdoqXEC
      RT @DrPetryna: #EULAR2020 #op0028 12 wk ph3 RELIEF study: Apremilast effectively relieves OU pain and OU number after 12

      Olga Petryna DrPetryna

      5 years 3 months ago
      #EULAR2020 #op0028 12 wk ph3 RELIEF study: Apremilast effectively relieves OU pain and OU number after 12 wks of 30 mg bid Rx. Great proportion of APR PTs achieved >10 mm &>30 mm improvement in OU pain @RheumNow https://t.co/p71sz9XL0e
      RT @drdavidliew: Lots of talk about best bDMARDs in RA-ILD, but what about in RA-assoc bronchiectasis?

      @Yuz6Yusof found

      David Liew drdavidliew

      5 years 3 months ago
      Lots of talk about best bDMARDs in RA-ILD, but what about in RA-assoc bronchiectasis? @Yuz6Yusof found rituximab had better 'lung survival' vs TNFi (similar baseline stats) Something to consider in these difficult-to-treat pts? @LeedsBRC Newcastle THU0143 #EULAR2020 @RheumNow https://t.co/XpffkDNqhU
      RT @drdavidliew: For patients on bDMARDs having surgery, we worry about post-op delayed wound healing.

      In this Japanese

      David Liew drdavidliew

      5 years 3 months ago
      For patients on bDMARDs having surgery, we worry about post-op delayed wound healing. In this Japanese cohort, TCZ use was a risk factor. Unclear if meds withheld, but given IL-6 upreg in wound healing, it's plausible TCZ might have worse outcomes?? SAT0047 #EULAR2020 @RheumNow https://t.co/HVIKPplwiA
      RT @Janetbirdope: Hand OA Rx strikes out. HCQ Rx neg and colchicine Trial negative. I wouldn’t put hand OA as same cat

      Janet Pope Janetbirdope

      5 years 3 months ago
      Hand OA Rx strikes out. HCQ Rx neg and colchicine Trial negative. I wouldn’t put hand OA as same category of no Rx as for SSc and Sjogrens but agree though nuts to crack @eular_org @CRASCRRheum @earlyarthritis #EULAR2020 https://t.co/QRe3UpKpbz
      RT @philipcrobinson: Awesome colchicine data from @CatherineL_Hill @samwhittle and others: Colchicine is not effective f

      Dr Philip Robinson philipcrobinson

      5 years 3 months ago
      Awesome colchicine data from @CatherineL_Hill @samwhittle and others: Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH) Abstract FRI0399 #EULAR2020 @RheumNow https://t.co/NVw9fo55dc https://t.co/LfHZVQTwIf
      RT @KDAO2011: #EULAR2020 THU0260 LESS IS BEST when it comes to steroids: Singapore 10 yr retrospect SLE study noted GCs

      k dao KDAO2011

      5 years 3 months ago
      #EULAR2020 THU0260 LESS IS BEST when it comes to steroids: Singapore 10 yr retrospect SLE study noted GCs dose is an independent predictor of mortality for hospitalized infection even when adjusted for disease activity.
      RT @DrMAUrsani: #tacrolimus #prograf is non inferior to #MMF #cellcept in #lupus #nephritis induction. We’ve been doin

      Mohammad A. Ursani MD, RhMSUS DrMAUrsani

      5 years 3 months ago
      #tacrolimus #prograf is non inferior to #MMF #cellcept in #lupus #nephritis induction. We’ve been doing it for years but great to see some solid RCT data behind this. #rheumatology #SLE #autoimmune https://t.co/CblD4GaXCp
      RT @KDAO2011: #EULAR2020 Dr. V Ritschl:EULAR Task Force on Patient Adherance: 30-80% of pts do not adhere to Rx. resulti

      k dao KDAO2011

      5 years 3 months ago
      #EULAR2020 Dr. V Ritschl:EULAR Task Force on Patient Adherance: 30-80% of pts do not adhere to Rx. resulting in ⬆️dz severity, pain, fatigue, depression, decreased in function, physical activity. HCPs should discuss adherance reg. & explore factors affecting adherance. @RheumNow
      Your #RA patients in low disease or remission, do you maintain, reduce or stop DMARDs #EULAR2020

      Dr. John Cush RheumNow

      5 years 3 months ago
      Your #RA patients in low disease or remission, do you maintain, reduce or stop DMARDs #EULAR2020
      How well do you know this week's rheumatology news?
      Take the rheumIQ quiz
      Take the RheumIQ Quiz

      Catch up on Conference Podcasts

      ×